Verve Therapeutics
VERV
#6830
Rank
C$0.64 B
Marketcap
$7.26
Share price
9.83%
Change (1 day)
-23.33%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.28

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.38. In 2022 the company made an earnings per share (EPS) of -$4.04 a decrease over its 2021 EPS that were of -$3.49.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.285.97%
2022-$4.0415.54%
2021-$3.4961.32%
2020-$2.17